Acrivon Therapeutics, Inc. (ACRV) Insider Trading

Name: Acrivon Therapeutics, Inc. (ACRV) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 2, 2026): Levin Michaela (Chief Business Officer): Grant/Award of 30,000 shares.

Get alerted when insiders trade ACRV

Email address

Loading company data...

Beta

Loading company details...

Beta